2012
DOI: 10.1007/s00066-011-0045-4
|View full text |Cite
|
Sign up to set email alerts
|

Limited disease of extra-pulmonary small cell carcinoma

Abstract: Nodal involvement did not worsen prognosis. Local control was excellent irrespective of local treatment modality and the leading cause of failure was distant metastasis. Therefore, systemic treatment should not be omitted. Prophylactic cranial irradiation might be dispensable but discussed for head and neck malignancies.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
4
0

Year Published

2012
2012
2019
2019

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 13 publications
(5 citation statements)
references
References 27 publications
1
4
0
Order By: Relevance
“…However, there are underlying confouding factors including non-random patient allocation and limited sample size. Moreover, the overall rate of intracranial failure is only 12% at 5-years which is comparable to other series on extra-pulmonary small cell carcinoma (EPSCC) (De Caluwé et al, 2017; Naidoo et al, 2013; Müller et al, 2012). However, these patients did not undergo serial brain imaging during their follow-up and therefore the failure rate should be interpreted with caution.…”
Section: Discussionsupporting
confidence: 72%
“…However, there are underlying confouding factors including non-random patient allocation and limited sample size. Moreover, the overall rate of intracranial failure is only 12% at 5-years which is comparable to other series on extra-pulmonary small cell carcinoma (EPSCC) (De Caluwé et al, 2017; Naidoo et al, 2013; Müller et al, 2012). However, these patients did not undergo serial brain imaging during their follow-up and therefore the failure rate should be interpreted with caution.…”
Section: Discussionsupporting
confidence: 72%
“…Preoperative radiotherapy is applied in rectal cancer (Sauer et al, 2012), postoperative treatment in breast cancer (Darby et al). Yet, also rare tumor entities like sarcoma and small cell carcinoma are treated with radiotherapy (Eckert et al, 2010a,b; Muller et al, 2012). Despite modern radiation techniques and advanced multimodal treatments local failures and distant metastases often limit the prognosis, especially due to limited salvage treatments (Muller et al, 2011; Zhao et al, 2012).…”
Section: Radiotherapymentioning
confidence: 99%
“…However it has been suggested that EPSCC should be managed similarly to SCLC. Therefore, multimodal therapy has become standard for LD of EPSCC [16,17,18,19]. In EPSCC patients with ED, systemic chemotherapy is the major treatment modality.…”
Section: Discussionmentioning
confidence: 99%